Oncology & Cancer

Genomic score predicts patients' progression to multiple myeloma

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of blood cancer, begins ...

page 2 from 6